Elixirr International (ELIX) investor relations material

Executive summary

• Achieved record half-year revenue of £71.4m, up 35% year-over-year, with 17% organic growth and five record months, reflecting strong organic and inorganic strategies.

• Completed the largest acquisition to date, TRC Advisory, expanding US presence, industrial sector capabilities, and adding six new Partners.

• Transitioned from AIM to the Main Market of the London Stock Exchange on 1 July 2025, enhancing capital access and market profile.

• Expanded gold client base from 22 to 31 year-over-year, with record months, increased brand recognition, and high employee share plan participation (71%).

• AI consulting is a major growth area, with £10m in contracted AI-specific revenues since the start of 2024 and a projected 27% market growth in 2025.

Financial highlights

• Revenue for H1 2025 reached £71.4m, up 35% year-over-year; gross profit up 40% to £24.3m, with a gross margin of 34%.

• Adjusted EBITDA rose 42% to £21.5m, with a 30% margin; adjusted profit before tax up 38% to £20.1m.

• Adjusted diluted EPS increased 35% to 29.0p; free cash flow up 12% to £7.9m; net debt at £6.8m.

• Revenue per client-facing partner rose from £2.1m to £2.3m year-over-year.

• Cross-sell revenue from acquisitions reached nearly £15m in the period, with over £60m since IPO.

Outlook and guidance

• Board confident in delivering organic FY25 results in line with market expectations, further enhanced by TRC acquisition.

• Short-term goal to enter FTSE 250 within 6–12 months, targeting £515m market cap.

• Medium-term ambition to reach £1bn market cap (unicorn status) in 3–5 years with 20–30% annual growth.

• Long-term aim to become a FTSE 100 company, targeting £4.5bn market cap.

• Continued focus on both organic and selective inorganic growth, with 1–2 acquisitions per year.